Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Company News

Ligand's Panretin recommended in Europe

July 17, 2000 7:00 AM UTC

The Committee for Proprietary Medicinal Products (CPMP) recommended approval for LGND's Panretin alitretinoin gel to treat AIDS-related Kaposi's sarcoma. Ferrer Internacional will exclusively market t...